MMJ Recs

OCTOBER 13, 2023

For patients seeking access to this valuable form of treatment, it’s essential to understand the complex web of regulations, legal requirements, and rights surrounding medical marijuana in the Golden State. This made the state a leader in the regulated cannabis industry, setting an example for others to follow.

Patients 52

Patients Law Cultivation Dispensary 52

Veriheal

OCTOBER 1, 2020

All over the world, governments are moving towards legalizing or at least decriminalizing, cannabis. African, Asian, American, European, and other countries have all been following the global cannabis movement, whether for recreational or medicinal purposes. When we speak of the UK, think England, Scotland, Wales, and Northern Ireland.

Legalization 104

Legalization Oil Medicine Media 104

Cannabis Law Report

AUGUST 21, 2019

PUBLISHER: CANNABIS LAW REPORT. Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said current treatments for adults suffering severe symptoms were “not cost effective”. This would answer questions about safety and efficacy, they said.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

MMJ Recs

OCTOBER 5, 2023

With a growing number of MMJ dispensaries, a comprehensive set of laws, and a streamlined process for obtaining a medical marijuana card, the state has become a hub for patients seeking alternative treatments. These laws are designed to protect patients, provide access to treatment, and prevent abuse.

Dispensary 52

Dispensary Patients Treatment Conditions 52

Cannabis Law Report

DECEMBER 26, 2021

The patent relates to improved technology for detection and maintenance of the optimal therapeutic psychedelic state, which Entheon intends to study through the monitoring of electroencephalogram (EEG) biomarkers in order to optimize the treatment of neuropsychiatric conditions. US Provisional Patent Filed. About Entheon Biomedical Corp.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis problem.

Research and Development 108

Research and Development Data THC Clinical Trials 108

MMJ Recs

MARCH 2, 2024

What to Expect at Ohio Medical Cannabis Dispensaries In Ohio medical cannabis dispensaries, patients can anticipate a welcoming and professional environment focused on holistic wellness. While browsing, you’ll encounter a diverse range of cannabis products, including flower, edibles, tinctures, and more.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

OCTOBER 6, 2021

Delic Labs is a federally authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development. Delic Labs is also a leading cannabis analytical and research company boasting clients that include some of the largest brands in the world. About DELIC Corp.

Research and Development 52

Research and Development Extraction Treatment Safety 52

Cannabis Law Report

APRIL 13, 2022

Securing a Dealer’s License to accompany its existing research exemptions would cement Delic Labs’ position as the leader in psychedelic safety testing. The Company aims to establish consistent quality control standards as more patients and clinicians incorporate psychedelic compounds into treatment plans.

Research and Development 52

Research and Development Treatment Extraction Medicine 52

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52

Canna Law Blog

APRIL 13, 2019

The letters were sent “in response to their making unsubstantiated claims related to more than a dozen different products and spanning multiple product webpages, online stores and social media websites.” Specifically, the agency fears that. directions for use, warnings)?

CBD 90

CBD Safety Topical Food 90

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. COAs are generally issued by accredited laboratories and many states require sellers to include COAs with each cannabis or CBD product. Delta-8 is known to be successful in many cancer treatments.”.

THC 52

THC CBD Media Food 52

Veriheal

AUGUST 3, 2021

Medical cannabis patients in Florida must now sign a new standardized consent form in order to legally partake. Doctors also have a new set of procedures to follow to recommend medical cannabis. As if that wasn’t enough, patients are also advised in the state of Florida to check their medical cannabis supplies for mold!

Patients 97

Patients Medicine Programs Cannabis 97

Veriheal

MAY 17, 2021

There are 36 states in the United States that have chosen the legalization of medical cannabis for residents of their states. Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. District Attorneys Believe Medical Cannabis is a Lie.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

MMJ Recs

FEBRUARY 29, 2024

The landscape of medical marijuana has evolved, offering patients alternative avenues for accessing therapeutic cannabis. In Florida, licensed Medical Marijuana Treatment Centers (MMTCs) are authorized to cultivate, process, and dispense medical marijuana to qualified patients.

Cultivation 52

Cultivation Marijuana Environment Patients 52

Veriheal

MARCH 1, 2022

The campaign manager of the ‘Yes on 109’ campaign that helped see the measure passed, Sam Chapman, told media sources, “There’s a huge breadth of expertise on this board from harm reduction experts to folks that have experience working with different populations that stand to benefit from having access to psilocybin therapy.

Therapy 98

Therapy Programs Microdosing Medicine 98

SpeedWeed

JUNE 9, 2021

Consumers in Michigan have even more options to purchase cannabis with the launch of a new license type for marijuana business operators announced recently by state regulators. Businesses licensed as marijuana delivery operators are permitted to purchase cannabis products from cultivators and manufacturers for delivery to customers’ homes.

Safety 40

Safety Access Cannabis Programs 40

Cannabis Law Report

SEPTEMBER 15, 2021

Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties. Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant.

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ will be utilizing its new products for an FDA approved treatment of multiple sclerosis (MS) and Huntington’s disease (HD). For media inquiries please contact: Michael Sharp.

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

JULY 24, 2021

This expansive patent would allow Mydecine to scale its coverage in drug development research in lieu of promising discoveries and FDA-approval progress for novel therapeutics, including granting Breakthrough Therapy Designation to MDMA for the treatment of PTSD in recent years. For more information, please contact: Media Contacts.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

JANUARY 24, 2022

–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Edwin (Ed) Tucker, M.D., Media: Liz Melone. CAMBRIDGE, Mass.–(BUSINESS Goldfinch Bio: Investors: Hannah Deresiewicz.

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

The Blunt Truth

AUGUST 13, 2019

On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. The public hearing attracted over 100 speakers and 2000 participants. The FDA has historically been passive in its oversight of CBD products.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

CannaMD

AUGUST 19, 2020

Can cannabis help treat the coronavirus? CannaMD takes a look at everything we know about cannabis and COVID-19 so far – separating science from spectacle, and highlighting key findings that might even surprise the most seasoned medical marijuana supporters. Coronavirus Basics. Terpenes and CBD: Twice as Effective.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. Leadership hires in clinical science, regulatory affairs, clinical safety, quality and manufacturing, in preparation for phase III, new compounds and additional indications.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

AUGUST 3, 2021

Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin makes no medical, treatment or health benefit claims about Cybin’s proposed products.

Clinical Trials 105

Clinical Trials Events Treatment Banking 105

Canna Law Blog

APRIL 3, 2020

What we don’t need in this situation are companies preying on consumers by promoting products with fraudulent prevention and treatment claims. This is some of the language included with the products that the FDA deemed unlawful: Corona virus treatment. These warning letters are just the first step.

CBD 61

CBD Tincture Treatment Media 61

Cannabis Law Report

FEBRUARY 17, 2022

WORCESTER – The Cannabis Control Commission (Commission) is alerting patients and consumers to its quarantine order (Order), issued October 18, 2021, mandating that ACK Natural, LLC, a colocated medical- and adult-use licensee, recall all products with unverifiable mycotoxin test results sold to its consumers and patients. PRESS RELEASE.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Cannabis Law Report

MAY 26, 2022

So we need to discuss openly and critically how we can remain balanced and ensure the potential of psychedelics can be optimised without compromising safety.”. And how do we make sure treatments are safe, accessible, and inclusive? Learn more about ICPR 2022 by connecting on social media using the #ICPR2022 hashtag.

Research and Development 52

Research and Development Therapy Policy Media 52

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

announced that the FDA would hold a public hearing on May 31 st to give stakeholders an opportunity to comment on new steps to advance the agency’s continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products. Today FDA Commissioner Scott Gottlieb, M.D.,

CBD 40

CBD Research and Development Safety Therapy 40

The Blunt Truth

MAY 26, 2020

In his statement, Commissioner Hahn noted that the FDA was working on: 1) continuing to educate the public on the risks of CBD; 2) seeking reliable data on the safety and benefits of CBD, including opening the public docket on the matter; and 3) monitoring the marketplace for the sale and marketing of unapproved drugs.

CBD 103

CBD Hemp Programs Food 103

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Doctors can prescribe Epidyolex – an oral solution of cannabidiol, which comes from the cannabis plant – if they think it will help sufferers. What is Epidyolex?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Alchimia

MARCH 16, 2016

Although a balanced nutrition – and regular brain stimulation – can have protective and preventive effects , we still don’t have any effective treatment for Alzheimer’s disease once it is active. How does cannabis combat Alzheimer’s disease? Cannabis patient. See studies #2, 3, 4, 6, 9, 10).

Cannabinoids 76

Cannabinoids Research and Development Treatment Patients 76

Cannabis Law Report

FEBRUARY 28, 2022

Show More According to the Drug Enforcement Administration (DEA), Schedule I drugs have “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” Mitchell et al., Divito & Robert F. 11 × 11. Psychiatry May Never Be the Same , N.Y. TIMES (Nov.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

DECEMBER 14, 2021

NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today that it is the first company to formulate medical cannabis extract vaporizer pen products in a UK-based manufacturing premises, licensed and approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Home Office.

Extraction 52

Extraction Patients Medicine Tincture 52

Cannabis Law Report

OCTOBER 15, 2021

At Kidney Week 2021, Goldfinch Bio will present multiple e-posters, including: The design of TRACTION-2, the ongoing Phase 2 clinical trial evaluating GFB-887 for the treatment of focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy (DN). Media: Liz Melone. CAMBRIDGE, Mass.–(BUSINESS Poster Number: INFO37.

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

Cannabis Law Report

JANUARY 13, 2020

Additional pipeline: Commence Phase 2b study of a cannabidiol formulation for the treatment of schizophrenia. subsidiary Greenwich Biosciences for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients two years of age or older. Media Enquiries: Sam Brown Inc. media enquiries.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

CannaMD

MARCH 19, 2020

As Florida’s leading medical cannabis physicians , CannaMD is committed to working closely with licensed dispensaries to ensure medical cannabis patients stay safe while continuing uninterrupted treatment during the coronavirus (COVID-19) crisis. Delivery options stay the same as usual. COLUMBIA CARE.

Policy 91

Policy Dispensary Patients Safety 91